Nanofluidic digital PCR for improved selection of metastatic colorectal cancer patients to anti-EGFR therapies

被引：0
|
作者：
Azuara, D. [1 ]
Santos, C. [1 ,2 ]
Lopez-Doriga, A. [3 ]
Montal, R. [1 ,2 ]
Sanjuan, X. [4 ]
Moreno, V. [3 ]
Tabernero, J. [5 ]
Montagut, C. [6 ]
Salazar, R. [1 ,2 ]
Capella, G. [1 ]
机构：
[1] Catalan Inst Oncol IDIBELL, Translat Res Lab, Lhospitalet De Llobregat, Spain
[2] Catalan Inst Oncol IDIBELL, Dept Med Oncol, Lhospitalet De Llobregat, Spain
[3] Catalan Inst Oncol IDIBELL, Biomarkers & Susceptibil Unit, Lhospitalet De Llobregat, Spain
[4] Univ Hosp Bellvitge IDIBELL, Dept Pathol, Lhospitalet De Llobregat, Spain
[5] Vall dHebron Inst Oncol, Dept Med Oncol, Barcelona, Spain
[6] Hosp del Mar, Dept Med Oncol, Barcelona, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
699
引用
收藏
页码：S154 / S155
页数：2
相关论文
共 50 条
  • [21] Prognostic value of the Glasgow Prognostic Score in metastatic colorectal cancer in the era of anti-EGFR therapies
    Johann Dréanic
    Marianne Maillet
    Marion Dhooge
    Olivier Mir
    Catherine Brezault
    François Goldwasser
    Stanislas Chaussade
    Romain Coriat
    Medical Oncology, 2013, 30
  • [22] IMMUNOLOGICAL EFFECTS OF DIFFERENT ANTI-EGFR ANTIBODIES IN METASTATIC COLORECTAL CANCER PATIENTS
    Manzoni, M.
    Delfanti, S.
    Rovati, B.
    Brugnatelli, S.
    Ronzoni, M.
    Perfetti, V
    Mariucci, S.
    Loupakis, F.
    Danova, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 33 - 33
  • [23] An Update on the Role of Anti-EGFR in the Treatment of Older Patients with Metastatic Colorectal Cancer
    Rosati, Gerardo
    Montrone, Michele
    Pacilio, Carmen
    Colombo, Alfredo
    Cicero, Giuseppe
    Paragliola, Fernando
    Vaia, Angelo
    Annunziata, Luigi
    Bilancia, Domenico
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
  • [24] Metastatic colorectal carcinoma patients: The Glasgow Prognostic Score (GPS) at the era of anti-EGFR therapies
    Dreanic, J.
    Maillet, M.
    Dhooge, M.
    Cessot, A.
    Mir, O.
    Brezault, C.
    Goldwasser, F.
    Chaussade, S.
    Coriat, R.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S525 - S525
  • [25] A synonymous EGFR polymorphism predicting responsiveness to anti-EGFR therapy in metastatic colorectal cancer patients
    Bonin, Serena
    Donada, Marisa
    Bussolati, Gianni
    Nardon, Ermanno
    Annaratone, Laura
    Pichler, Martin
    Chiaravalli, Anna Maria
    Capella, Carlo
    Hoefler, Gerald
    Stanta, Giorgio
    TUMOR BIOLOGY, 2016, 37 (06) : 7295 - 7303
  • [26] Current concepts of anti-EGFR targeting in metastatic colorectal cancer
    Doleschal, Bernhard
    Petzer, Andreas
    Rumpold, Holger
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [27] Anti-EGFR Therapy to Treat Metastatic Colorectal Cancer: Not for All
    Martins, Marta
    Mansinho, Andre
    Cruz-Duarte, Raquel
    Martins, Soraia Lobo
    Costa, Luis
    TARGETED THERAPY OF COLORECTAL CANCER SUBTYPES, 2018, 1110 : 113 - 131
  • [28] The Emerging Role of NRAS Mutations in Colorectal Cancer Patients Selected for Anti-EGFR Therapies
    Meriggi, Fausto
    Vermi, William
    Bertocchi, Paola
    Zaniboni, Alberto
    REVIEWS ON RECENT CLINICAL TRIALS, 2014, 9 (01) : 8 - 12
  • [29] Potential biomarkers for anti-EGFR therapy in metastatic colorectal cancer
    Yang, Jiao
    Li, Shuting
    Wang, Biyuan
    Wu, Yinying
    Chen, Zheling
    Lv, Meng
    Lin, Yayun
    Yang, Jin
    TUMOR BIOLOGY, 2016, 37 (09) : 11645 - 11655
  • [30] Current Recommendations and Novel Strategies for the Management of Skin Toxicities Related to Anti-EGFR Therapies in Patients with Metastatic Colorectal Cancer
    Annunziata, Maria Carmela
    De Stefano, Alfonso
    Fabbrocini, Gabriella
    Leo, Silvana
    Marchetti, Paolo
    Romano, Maria Concetta
    Romano, Ivana
    CLINICAL DRUG INVESTIGATION, 2019, 39 (09) : 825 - 834
12345